Abstract
It has been proposed that amyloid-β peptide (Aβ) aggregation in the brain plays a major role in the pathogenesis of Alzheimer’s disease (AD). Real-time imaging technology for monitoring Aβ aggregation is a valuable approach for understanding the pathogenesis of AD. Quantum dots (QDs), which are fluorescent semiconductor nanocrystals, have evolved over the past decade as highly useful fluorescence probes for bio-nanoimaging due to their specific characteristics, such as nano-scale size, bright emission spectrum, long-term photostability, and multi-wavelength fluorescence emission by a single excitation. We have recently developed QD-labeled Aβ (QDAβ) nanoprobes which enable real-time imaging of Aβ aggregation, including oligomerization and fibrilization in vitro and in an intact cell system. In this chapter, we present the method for the preparation of QDAβ, as well as imaging and quantification of Aβ aggregation in vitro and in cultured cells. Furthermore, we also introduce a high-throughput microscopic drug-screening system for inhibiting Aβ aggregation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.